Stock CRVO CERVOMED INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights CervoMed Inc.

Equities

CRVO

US15713L1098

Delayed Nasdaq
Other stock markets
 13:50:19 2024-05-23 EDT 		5-day change 1st Jan Change
18.3 USD -3.73% Intraday chart for CervoMed Inc. -24.88% +139.84%
05-20 CervoMed Names William Elder CFO MT
05-15 Earnings Flash (CRVO) CERVOMED Posts Q1 Revenue $2.3M MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Earnings Flash (CRVO) CERVOMED Posts Q1 Revenue $2.3M
MT
CervoMed Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Cervomed Inc. Publishes Positive Results from AscenD-LB Phase 2a Trial in Peer-Reviewed Journal That Supports the Therapeutic Potential of Neflamapimod in Dementia with Lewy Bodies
CI
CervoMed Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
CervoMed Inc. Announces Oral Presentation at CTAD 2023 Highlighting Phase 2b Neflamapimod Program for the Treatment of Patients with Dementia with Lewy Bodies
CI
CervoMed Inc. Announces Publication in Neurology® Results Showing A Blood Test At Study Entry Identified Patients Who Demonstrated Substantial Response to Neflamapimod in Dementia with Lewy Bodies
CI
Reverse Split: 1 of 1.5
FA
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CRVO Stock
  4. News CervoMed Inc.
  5. Highlights